This grant is for Small Business Concerns (SBCs) seeking to advance the therapeutic development of psychoplastogenic compounds. The primary objective is to support drug discovery and development efforts targeting Substance Use Disorders (SUDs). This funding opportunity encourages innovative research into novel compounds and related models that can contribute to new treatments for addiction, specifically excluding alcohol use disorder. Applicants should focus on developing these compounds for future therapeutic use. It is important to note that this grant explicitly excludes clinical trials, focusing instead on preclinical research, compound identification, and model development phases. This initiative aims to foster significant advancements in the understanding and treatment of SUDs through novel pharmacological approaches.
Opportunity ID: 341426
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-23-017 |
| Funding Opportunity Title: | Therapeutic Development of Psychoplastogenic Compounds for Substance Use Disorders (R43/R44 – Clinical Trials Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jun 24, 2022 |
| Last Updated Date: | Jun 24, 2022 |
| Original Closing Date for Applications: | Nov 18, 2022 |
| Current Closing Date for Applications: | Nov 18, 2022 |
| Archive Date: | Dec 24, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $2,500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. See Full Announcement for additional details on eligibility |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) seeks grant applications from small business concerns (SBCs) to develop psychoplastogenic compounds and related models for drug discovery and drug development for Substance Use Disorders (SUD), excluding alcohol use disorder. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-017.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 341426 Full Announcement-RFA-DA-23-017 -> RFA-DA-23-017-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00275200 | Oct 18, 2022 | Nov 18, 2022 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278532 | Nov 16, 2022 | Nov 18, 2022 | View |
Package 1
Mandatory forms
341426 RR_SF424_5_0-5.0.pdf
341426 PHS398_CoverPageSupplement_5_0-5.0.pdf
341426 RR_OtherProjectInfo_1_4-1.4.pdf
341426 PerformanceSite_4_0-4.0.pdf
341426 RR_KeyPersonExpanded_4_0-4.0.pdf
341426 RR_Budget_3_0-3.0.pdf
341426 PHS398_ResearchPlan_4_0-4.0.pdf
341426 SBIR_STTR_Information_3_0-3.0.pdf
341426 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
341426 RR_SubawardBudget30_3_0-3.0.pdf
341426 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
341426 RR_SF424_5_0-5.0.pdf
341426 PHS398_CoverPageSupplement_5_0-5.0.pdf
341426 RR_OtherProjectInfo_1_4-1.4.pdf
341426 PerformanceSite_4_0-4.0.pdf
341426 RR_KeyPersonExpanded_4_0-4.0.pdf
341426 RR_Budget_3_0-3.0.pdf
341426 PHS398_ResearchPlan_5_0-5.0.pdf
341426 SBIR_STTR_Information_3_0-3.0.pdf
341426 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
341426 RR_SubawardBudget30_3_0-3.0.pdf
341426 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
